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Pulmonary DCs are the critical APCs that rec-
ognize and capture all types of antigens in the 
lung. They then ferry and present these anti-
gens in the lung-draining LN (LLN).  These anti-
gens include viruses, bacteria, fungi, and even 
in the case of autoimmunity, self-antigens. De-
spite their essential roles, very little is known 
about the basic mechanisms or selectivity by 
which pulmonary DCs acquire pathogens or 
host cells and how they subsequently regulate 
the immune response.
Three DC types have been described in the 
naive lung: plasmacytoid DCs and two migratory 
DCs,  CD103+  and  CD11bhi  DCs  (Vermaelen 
and Pauwels, 2004; Sung et al., 2006; Jakubzick 
et al., 2008a). The functional roles of pulmo-
nary  DC  subsets  are  beginning  to  unfold 
(Plantinga et al., 2010). An in vitro study ex-
tracting LLN migratory DCs containing soluble 
OVA (sOVA) suggested that pulmonary CD103+ 
DCs  could  cross-present  antigens  on  MHC 
class I, whereas CD11bhi DCs were responsible 
for antigen presentation on MHC class II (Belz 
et al., 2007; del Rio et al., 2007). In vivo studies, 
using  deletion  approaches  and  transcription 
factor  knockout  mice  for  the  depletion  of   
DC subsets, revealed that pulmonary CD103+ 
DCs are required for a CTL response to viruses 
(GeurtsvanKessel et al., 2008; Kim and Braciale, 
2009; Edelson et al., 2010). Yet it remains un-
clear how the DCs acquired the virus for pre-
sentation. DCs may take up virus directly or by 
ingestion of an infected cell such as a dying   
epithelial  cell.  Recognition  and  removal  of   
cells undergoing apoptosis and other forms of 
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Cells undergoing programmed cell death (apoptosis) are removed in situ by macrophages 
and dendritic cells (DCs) through a specialized form of phagocytosis (efferocytosis). In the 
lung, there are two primary DC subsets with the potential to migrate to the local lymph 
nodes (LNs) and initiate adaptive immune responses. In this study, we show that only 
CD103+ DCs were able to acquire and transport apoptotic cells to the draining LNs and 
cross present apoptotic cell–associated antigen to CD8 T cells. In contrast, both the 
CD11bhi and the CD103+ DCs were able to ingest and traffic latex beads or soluble antigen. 
CD103+ DCs selectively exhibited high expression of TLR3, and ligation of this receptor led 
to enhanced in vivo cytotoxic T cell responses to apoptotic cell–associated antigen. The 
selective role for CD103+ DCs was confirmed in Batf3/ mice, which lack this DC subtype. 
Our findings suggest that CD103+ DCs are the DC subset in the lung that captures and 
presents apoptotic cell–associated antigen under homeostatic and inflammatory conditions 
and raise the possibility for more focused immunological targeting to CD8 T cell responses.
© 2011 Desch et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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programmed cell death occur by specific recognition of li-
gands and uptake processes termed efferocytosis (deCathelineau 
and Henson, 2003), a property which is shared by macro-
phages and some subsets of DCs. Thus, within the splenic DC 
populations, CD8+ DCs selectively acquire apoptotic cells. 
This selectivity was also observed in nonlymphoid DC sub-
sets in mouse liver and rat intestine (Iyoda et al., 2002; Qiu   
et al., 2009); however, the expression of CD103 was not in-
vestigated. Moreover, there is indirect evidence that CD103+ 
DCs in the skin capture self-apoptotic cells during homeo-
stasis (Bedoui et al., 2009). CD103+ DCs, including pulmo-
nary CD103+ DCs, share many similar properties with the 
lymphoid CD8+ DCs of the spleen, including developmental 
regulation by Flt3 and transcription factors Irf8 and Batf3 
(Edelson et al., 2010), and the capacity to cross-present antigen. 
However, besides their differences in location, there is one 
property they do not share, which is the capacity to migrate 
down afferent lymphatics (Smith and Fazekas de St Groth, 
1999). The finding that not all DCs migrate to the draining 
LN when injected into nonlymphoid sites such as the skin 
further supports the need to understand the functional roles 
of tissue-resident DCs.
Accordingly, to delineate functional roles of the different 
pulmonary DCs, we set out to identify which migratory DC 
population was capable of acquiring apoptotic cells in the tis-
sue for presentation of contained antigen in the LLN. We   
hypothesized and now show that pulmonary CD103+ DCs 
selectively express TLR3 and exhibit preferential uptake and 
trafficking  of  apoptotic  cells  compared  with  the  CD11bhi 
DCs. Furthermore, only the CD103+ migratory DCs were 
capable of cross-presenting airway apoptotic cell–associated 
antigen in the LLN.
RESULTS AND DISCUSSION
CD103+ DCs but not CD11bhi DCs selectively traffic 
apoptotic cells to the draining LN
Intranasal (i.n.) delivery of CFSE-labeled apoptotic thymo-
cytes showed that of the migratory DCs in the draining LNs, 
only CD103+ DCs captured apoptotic cells (Fig. 1 A). This 
was true whether or not LPS was included in the instillate to 
enhance DC migration (Jakubzick et al., 2008a). Further-
more, essentially all the CFSE+ cells were located within the 
CD103+CD11c+MHCIIhi migratory DC population assessed 
by FACS, and nearly all efferocytic cells were localized to the 
T cell zone of the LLN by immunohistochemistry (Fig. 1,   
A and B). This selectivity was striking because our previous 
study showed that bead particles, soluble protein, and free 
CFSE delivered i.n. are trafficked to the LLN by both pulmo-
nary CD103+ and CD11bhi DCs (Jakubzick et al., 2008a). 
Importantly, apoptotic cells in the lung, for example during reso-
lution of inflammation, can be taken up by alveolar macrophages 
Figure 1.  Apoptotic cell trafficking to the LLN by lung CD103+ DCs. 
(A) C57BL/6 mice were inoculated i.n. with CFSE-labeled apoptotic thymo-
cytes in the absence (top) or presence (bottom) of 2 µg LPS. Control mice 
received no cells. LLN cells were isolated 24 h later and analyzed by flow 
cytometry. Efferocytic cells were identified as CFSE+, and migratory DCs 
were identified as CD11c+MHCIIhi. Overlays show CFSE+ cells (black) and 
total live cells or total migratory DCs (yellow) as indicated. Numbers indi-
cate frequency of CFSE+ DCs that express CD103. Representative data  
of four independent experiments with three mice/group are shown.  
(B) Skin-draining LNs (SLNs) and LLNs were sectioned 24 h after delivery 
of CFSE-labeled apoptotic thymocytes. Tissue sections were stained with 
anti-B220 (red) and CFSE (green). Bars, 40 µm. (C) 24 h after i.n. delivery 
of CFSE-labeled apoptotic thymocytes, the frequency of CD103+ DCs 
among total CFSE+ cells was calculated in the LLN during the indicated 
times throughout an acute inflammatory response. As a control, PKH 26 
cell-free tracer was used to track migratory DCs to the LLN. Data repre-
sent the results of three independent experiments. (D) C57BL/6 mice were 
inoculated i.n. with CFSE-labeled apoptotic BALB/c thymocytes, human 
neutrophils, or murine lung epithelial cell line (MLE 12). Uptake by migra-
tory DCs was accessed 24 h later. (C and D) Each dot represents an indi-
vidual mouse. Bars represent the mean of the individual mice per group.
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as well as by DCs, a competitive effect which required admin-
istration of large enough numbers of apoptotic cells to over-
come this potential competition.
It was possible that CD11bhi DCs might gain the property 
of efferocytosis during an acute inflammatory response, either 
from the change in milieu and/or because a quantitative ad-
vantage exists for CD11bhi DCs when they preferentially ac-
cumulate in the lung during inflammation (Kirby et al., 2006; 
GeurtsvanKessel et al., 2008, 2009; Kim and Braciale, 2009; 
Lukens et al., 2009; Ballesteros-Tato et al., 2010). Accordingly, 
inflammation was induced by i.n. delivery of 2 µg LPS 6, 3, 2, 
or 1 d before delivery of CFSE-labeled apoptotic cells. 24 h 
after apoptotic cell delivery, DCs were analyzed for uptake 
and trafficking of CFSE+ apoptotic cells to the LLN. How-
ever, regardless of the time apoptotic cells were introduced 
within an acute inflammatory environment, CD103+ DCs 
were consistently found to preferentially transport apoptotic 
cells to the LLN (Fig. 1 C). Therefore, even in the context of 
acute inflammation where epithelial permeability is enhanced, 
CD11bhi DCs do not contribute substantially to the traffick-
ing of apoptotic cells to the LLN.
To ascertain whether the acquisition and trafficking of 
apoptotic cells by CD103+ DCs was conserved using differ-
ent apoptotic cell sources, C57BL/6 mice were given CFSE-
labeled apoptotic BALB/c thymocytes, human neutrophils, or 
murine lung epithelial cells and analyzed for CFSE+ migra-
tory DCs in the LLN 24 h later. Even when mouse strains and 
species were incongruent, pulmonary CD103+ DCs still main-
tained their selectivity for the transport of apoptotic cells to 
the LLN (Fig. 1 D and Fig. S1). Overall, these data demon-
strate that CD103+ DCs are efferocytic.
CD103+ DCs preferentially localize along the airways and 
line the vasculature (Sung et al., 2006). Because there might 
be a locational advantage that allows CD103+ DCs to acquire 
apoptotic cells, co-delivery of particulate beads and apoptotic 
cells was examined. Initial experiments assessed the uptake 
and trafficking of 1-, 2-, 3-, and 4.5-µm diameter latex beads 
administered along with LPS to enhance DC migration and 
allow detection of larger size beads in the draining LN 
(Jakubzick et al., 2008a). As expected, both migratory pulmo-
nary DC subsets transported the beads to the draining LNs; 
however, the frequency of bead-positive CD103+ DCs slightly 
increased as bead size increased (Fig. 2 A). Unlike apoptotic 
Figure 2.  CD103+ DCs preferentially take up apoptotic cells, 
whereas both CD103+ and CD11bhi cells take up particulate beads. 
(A) C57BL/6 mice were inoculated i.n. with 30 × 106 latex beads of the 
indicated size, and the total number of bead+ cells (top) or frequency of 
CD103+ DC among all bead+ cells (bottom) was determined 24 h later. NA 
indicates not quantitated because of the paucity of migrated beads. Data 
shown are representative of three independent experiments. Mean ± SEM 
is shown. (B) C57BL/6 mice were inoculated i.n. with 30 × 106 latex beads 
(1 µm) or OVA-FITC, and 24 h later, LLN bead+ or OVA-FITC+ migratory DCs 
were analyzed by flow cytometry. (C) LLNs were harvested from mice 
inoculated with beads alone (top), CFSE-labeled apoptotic cells (middle), 
and beads with CFSE-labeled apoptotic cells (bottom). LLNs were gated on 
bead+ cells (blue), CSFE+ cells (yellow), or CSFE+bead+ cells (green). Histo-
grams show CD103 expression on gated cells (CD103lo = CD11bhi DCs; 
CD103hi = CD103+ DCs). Data are representative of two independent ex-
periments with three mice/group. (D) Lung tissue was harvested 2 h after 
i.n. inoculation with CFSE-labeled apoptotic cells, and the frequency of 
the indicated DC subsets was determined by flow cytometry. Data are 
representative of three independent experiments. Error bars indicate SEM. 
(E) CD103+ or CD8+ DCs were isolated from lungs (top) and spleen (mid-
dle) and cultured with PBSE-labeled apoptotic cells for 4 h. The frequency 
of apoptotic cell uptake for each population among total PBSE+ DCs was 
calculated (bottom). Each dot represents the mean of triplicates from 
three independent experiments. Error bars indicate SEM.
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uptake by DCs in the lung, lungs were harvested, and DCs 
were sorted 2 h after i.n. delivery of the tagged apoptotic cells. 
By immunofluorescence analysis, 30% of total lung CD103+ 
DCs had associated apoptotic cell bodies compared with 7% 
of CD11bhi DCs (Fig. 2 D). The observation that after isola-
tion from the lung, a few CD11bhi CD11chiMHCIIhi cells 
contained apoptotic cells after cell sorting, whereas in the 
draining LN only CD103+ DCs contained apoptotic cells, 
suggests a possible explanation that CD11bhiCD11chiMHCIIhi 
DCs represent a heterogeneous population containing other 
monocytic-like cells, not yet identified, that can bind and/or 
ingest apoptotic cell bodies, which are unable to migrate to 
the LLN.
Moreover, in vitro uptake of apoptotic cells by pulmonary 
DCs was assessed. In culture, pulmonary CD103+ DCs pref-
erentially acquired apoptotic cells over CD11bhi DCs, albeit 
with less efficiency than splenic CD8+ DCs (Fig. 2 E). Putting 
the data together, we demonstrated that at the level of the 
lung parenchyma, CD103+ DCs appear selectively specialized 
to engulf apoptotic cells and subsequently transport these to 
the LLN.
CD103+ DCs cross-present apoptotic cell–associated antigen
Pulmonary CD103+ DCs have been directly shown in vitro to be 
specialized in cross-presentation (Belz et al., 2007; del Rio et al., 
2007). Because we have demonstrated in vivo a selective uptake 
of apoptotic cells by CD103+ DCs, the selective ability of these 
cells to cross present 
antigen in vivo was 
next examined using 
apoptotic thymocytes 
cells, beads are not malleable, therefore it may not be surpris-
ing that beads as large as 7-µm cells were not transported to 
the LLNs. Detectable DC transport of beads was limited to 
3-µm beads or smaller, as very few bead-carrying cells were 
found in LNs when ≥4.5-µm particles were instilled. Most 
notably, with 0.5- and 1-µm beads, CD103+ DCs not only 
trafficked beads at a greater frequency, but also quantitatively 
carried more beads per cell than CD11bhi DCs (Fig. 2 B and 
not depicted for 0.5 µm). The same quantitative observation 
was made for sOVA protein. That is, even though we have 
previously shown that CD11bhi DCs traffic sOVA at a higher 
frequency than CD103+ DCs (Jakubzick et al., 2008a), some 
CD103+ DCs have quantitatively more OVA per cell than 
CD11bhi DCs (Fig. 2 B). Thus, in general, CD103+ DCs appear 
to be more endocytic than CD11bhi DCs. Because 3-µm beads 
were the limiting bead size for DC trafficking, 2-µm beads 
were chosen for co-delivery experiments with apoptotic cells.
Co-delivery of apoptotic cells i.n. along with 2-µm latex 
beads revealed that CD103+ DCs either trafficked apoptotic 
cells alone or apoptotic cells with beads to the LLN. In con-
trast, CD11bhi DCs carried beads but not apoptotic cells to 
the LLN (Fig. 2 C). Because these data show that nonspecific 
airway  particulates  can  be  engulfed  and  transported  by 
CD11bhi DCs as well as CD103+ DCs to the LLN, the speci-
ficity of the CD103+ DCs in efferocytosis was not caused by 
failure of CD11bhi DCs to access phagocytic cargo.
Selective uptake of apoptotic cells by CD103+ DCs  
in the lung tissue
To determine whether the selectivity for apoptotic cell traf-
ficking to the LLN occurred at the level of recognition and 
Figure 3.  Efferocytic pulmonary CD103+ 
DCs are required for apoptotic cell acquisi-
tion, migration to the LLN, and cross- 
presentation. (A) Lung DC subsets from WT and  
Batf3/ mice were gated on CD11c+ and ana-
lyzed by flow cytometry for expression of  
MHCII, CD11b, and CD103. Cell were gated on 
MHCII+ (left) and SiglecF (middle) and plotted 
for CD11b and CD103 expression (right).  
(B) LLNs were isolated from WT and Batf3/ 
mice 24 h after inoculation with CFSE-labeled 
apoptotic cells. Cells were gated on live cells and 
analyzed for CD11c versus CD11b (top) or  
MHCII (bottom). Overlay plots show CFSE+ DCs 
(black) and all migratory DCs (gray). Data are 
representative of two independent experiments 
with three mice/group. (C) WT and Batf3/ 
mice were inoculated with a 1:1 mixture of 
CFSE-labeled OT-1 and OT-2 cells (2 × 106 total 
cells) 1 d before i.n. delivery of apoptotic WT 
cells, PBS, apoptotic OVA-expressing cells, or  
1 μg sOVA. T cell proliferation was assessed 3 d 
later. Data are representative of three indepen-
dent experiments with two to three mice/
group. (D) DC subsets were isolated from PBS-
perfused lung tissue, and mRNA was isolated 
for microarray analysis. Plots show fold change 
of the indicated genes in pulmonary CD103+ 
DCs versus CD11bhi DCs (top) or pulmonary 
CD11bhi DCs versus CD103+ DCs (bottom).JEM Vol. 208, No. 9  1793
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The data suggest a differential ability of the DC types to rec-
ognize and respond to pathogens.
TLR3 recognizes viral double-stranded RNA and is spe-
cifically expressed by CD103+ DCs. Therefore, we examined 
the ability of Poly I:C, a TLR3 agonist, to enhance IFN- 
production in proliferating OT-1 T cells after apoptotic cell–
associated  antigen  and  soluble  antigen  presentation.  Mice 
treated with Poly I:C and OVA apoptotic cells did not promote 
isolated from OVA-expressing mice (OVA apoptotic thymo-
cytes). To examine the CD103+ DC specificity for cross- 
presentation of cell-associated antigen, Batf3/ mice were 
used. Batf3/ mice lack lymphoid CD8+ DCs and non-
lymphoid CD103+ DC in multiple tissues including the 
lung and LLN (Fig. 3, A and B; Hildner et al., 2008; Edelson 
et al., 2010). As shown in Fig. 3 B, the lack of CD103+ DCs and 
trafficked CFSE-labeled apoptotic cells in LLN in the Batf3/ 
mice confirmed the requirement for this DC type.
Next, apoptotic cell–associated antigen presentation was 
assessed by CD103+ DCs. Mice were given i.v. a 1:1 ratio of 
CFSE-labeled OVA-specific OT-1 (CD8) and OT-2 (CD4) 
transgenic T cells 1 d before i.n. delivery of OVA-apoptotic 
thymocytes or sOVA. 3 d later, proliferation of OVA-specific 
T cells was measured. Strikingly, antigen from OVA apoptotic 
thymocytes was presented exclusively to CD8 T cells (Fig. 3 C). 
In contrast, instillation of sOVA induced both OT-1 and OT-2 
proliferation, i.e., both pulmonary DCs acquired and pre-
sented the antigen (Figs. 2 B and 3 C; Jakubzick et al., 2008a). 
Thus, only the pulmonary CD103+ DC acquired and traf-
ficked apoptotic cell–associated antigen and led to its cross-
presentation  to  antigen-specific  CD8 T  cells.  Unlike WT 
mice, presentation of apoptotic cell–associated antigen to   
either OT-1 or OT-2 T cells did not occur in Batf3/ mice 
(Fig. 3 C), further confirming the role for CD103+ DCs. 
However, this experiment does not exclude a possible role for 
lymphoid CD8+ DCs (also absent in the Batf3/ mice) for 
antigen presentation after CD103+ DCs transport antigen and 
arrive in the draining LN (Belz et al., 2004). Delivery of sOVA 
led to a skewed proliferative response of OT-2 T cells in the 
Batf3/ mice compared with WT mice, whereas in the WT 
mice the OT-1 T cell response was stronger, which is most 
likely attributable to the enhanced antigen trafficking and 
cross-presentation by the CD103+ DCs (Fig. 3 C).
Because  pulmonary  CD103+  DCs,  along  with  splenic 
CD8+ DCs, favor apoptotic cell uptake and cross-presentation, 
we examined levels of gene expression in the MHC class I 
and MHC class II pathway molecules in the former, as previ-
ously reported for splenic DCs (Dudziak et al., 2007). Indeed, 
pulmonary CD103+ DCs demonstrated enhanced gene ex-
pression  for  MHC  class  I  pathway  molecules,  whereas 
CD11bhi DCs displayed enhanced expression in several of the 
MHC class II pathway molecules (Fig. 3 D). The observation 
supports the suggested intrinsic capacity of CD103+ DCs to 
cross-present antigen, whereas CD11bhi DCs appear more   
effective at presentation via MHC class II. However, these find-
ings do not negate the ability for both pulmonary DCs to use 
all of the antigen-presenting pathways.
Cell-associated antigen presentation by CD103+ DCs  
along with TLR3 agonist enhances IFN- production  
and cytotoxicity from the proliferating OT-1 T cells
Unlike CD11bhi DCs, CD103+ DCs demonstrated selective 
expression of TLR3, along with CCR9, CXCR3, XCR1, 
and Cadm1 (Fig. 4 A and Table S1). In contrast, CD11bhi DCs 
expressed Clec4a1, TLR2, and TLR7 (Fig. 4 A and Table S1). 
Figure 4.  CD103+ DCs selectively express TLR3, which promotes 
IFN- production and CTL responses. (A) Expression of the indicated 
genes in pulmonary CD103+ DCs versus CD11bhi DCs (top) and pulmonary 
CD11bhi DCs versus CD103+ DCs (bottom). (B and C) WT (B) and Batf3/ (C) 
mice were inoculated with a 1:1 mixture of CFSE-labeled OT-1 and OT-2 
cells (2 × 106 total cells) 1 d before i.n. delivery of apoptotic OVA ± 10 µg 
Poly I:C (B) and apoptotic WT or OVA-expressing cells or sOVA ± 10 µg Poly 
I:C (C). 3 d later, the cells were assessed for proliferation (B) or IFN- pro-
duction (C). Data are representative of two independent experiments. Error 
bars indicate SEM. (D) OT-1 cells (1 × 106 total cells) were transferred into 
WT mice 1 d before inoculation with WT or OVA-expressing apoptotic  
cells ± 10 μg Poly I:C. 5 d later, mice were injected with a 1:1 ratio of CFSElo- 
labeled WT and CFSEhi-labeled OVA+ splenocytes. The presence of CFSElo and 
CFSEhi cells was assessed by flow cytometry 24 h later. Data are representa-
tive of two independent experiments with three mice/group. (E) Expression 
of the indicated genes in pulmonary CD103+ DCs versus CD11bhi DCs (top). 
Protein expression of CD36 and Clec9a (black line) on the indicated pulmo-
nary DC subsets was analyzed by flow cytometry. Isotype control is indi-
cated by the gray line. Gene expression analysis was performed on DC 
populations isolated independently on three separate days.1794 Efferocytic pulmonary dendritic cells | Desch et al.
organ-specific vaccines, perhaps targeting tissue-resident DCs 
might prove to be more efficacious.
It was unexpected that CD11bhi DCs under the conditions 
studied would neither acquire nor traffic apoptotic cells to the 
LLN because unlike splenic CD8 DCs, CD11bhi DCs arise 
from the monocytic linage that gives rise to macrophages 
(Landsman et al., 2007; Jakubzick et al., 2008b; Ginhoux et al., 
2009). Therefore, there appears to be a dichotomy between the 
monocytic DC and macrophage, in which macrophages effero-
cytose with greater efficiency than pulmonary CD11bhi DCs. 
Even though CD11bhi DCs do not appear to contribute sub-
stantially to airway apoptotic cell clearance, this finding does not 
negate the possibility that CD11bhi DCs could acquire apop-
totic or necrotic cells, or cellular contents, during an infection 
where some studies have demonstrated that in the LLN CD11bhi 
DCs in vitro can cross-present flu antigens (GeurtsvanKessel   
et al., 2009; Kim and Braciale, 2009; Ballesteros-Tato et al., 
2010). Influenza is a lytic virus providing CD11bhi DCs with 
free virions and necrotic cell debris. Alternatively, CD11bhi DCs 
could be cross-dressed because a recent study demonstrated 
that splenic CD8 DCs were more efficiently cross-dressed 
than CD8+ DCs (Wakim and Bevan, 2011).
In  conclusion,  we  demonstrate  a  major  functional  dif-
ference between the two pulmonary DC subsets, a selective 
skewing of apoptotic cell uptake by CD103+ DCs, and sub-
sequent cross-presentation of associated antigen. Lack of the 
CD103+ DCs in the Batf3/ mice prevented cross-presentation.   
These experiments suggest that a major determinant in   
this selectivity resides in the initial recognition and uptake of 
the apoptotic cells by DC subsets within the lung parenchyma. 
There are a host of potential receptors for apoptotic cell li-
gands that have been identified on phagocytes, including DCs, 
and future studies will need to identify these on the different 
DC subsets. Examination of the microarray screen of CD103+ 
versus CD11bhi DCs showed increased levels of messenger 
RNA (mRNA) for candidates such as CD36, DEC205, TIM-
1, TIM-3, TIM-4, and Clec9a. CD36 and Clec9a were con-
firmed by cell surface protein levels (Fig. 4 E and Table S1), 
which may provide a starting point for such investigation.
Accordingly, pulmonary CD103+ DCs are an attractive 
DC subtype to exploit in strategies to potentiate peripheral tol-
erance, or antiviral and antitumor immunity, given their intrin-
sic ability to engulf apoptotic cells, migrate to LNs, cross-present 
cellular antigen, and, with Poly I:C, promote cytotoxicity.
MATERIALS AND METHODS
Mice. CD45.1 and CD45.2 C57BL/6, 129/BL6 F2 (control for Batf3/ 
mice) OT-1, OT-2, CX3CR1gfp/gfp, and C57BL/6-Tg(ACTB-OVA)916Jen/J   
mice  were  purchased  from  Jackson  ImmunoResearch  Laboratories,  Inc. 
Batf3/ mice were provided by K. Murphy. Mice were used for experiments 
at 7–8 wk of age, housed in a specific pathogen-free environment at National 
Jewish Health, and used in accordance with protocols approved by the Insti-
tutional Animal Care and Utilization Committee.
Flow cytometry. Single-cell suspensions were obtained from whole lung, 
spleen, and LLN. All LLN data were individually harvested, not pooled, and 
analyzed. Prior to lung extraction, mice were perfused with 10 ml PBS.   
MHCII  cell–associated  antigen  presentation  (Fig.  4  B)   
but instead induced three times more IFN-–producing   
OT-1 T cells compared with mice treated with OVA apop-
totic cells alone (Fig. 4 C). sOVA in the presence of Poly I:C 
showed six times more IFN-–producing OT-1 T cells com-
pared with mice given sOVA alone (Fig. 4 C). In contrast, this 
enhancement was not observed in the Batf3/ mice, i.e., 
lacking the TLR3-expressing CD103+ DCs (Fig. 4 C).Thus, 
these data suggest that Poly I:C–induced IFN- production 
by antigen-specific CD8 T cells required the presence and 
antigen presentation of CD103+ DCs.
This evidence of CD8 T cell activation suggests a compara-
ble induction of cytotoxicity in the proliferating OT-1 T cells.   
To examine this, OT-1 T cells were adoptively transferred into 
mice 1 d before i.n. delivery of WT apoptotic thymocytes (as 
control) or OVA apoptotic thymocytes with PBS or with 10 µg 
Poly  I:C.  5  d  later, WT  splenocytes  and  OVA-expressing   
splenocytes were labeled with a low and high concentration of 
CFSE, respectively, and then delivered i.v. at a 1:1 ratio as targets 
for the measurement of antigen-specific cytotoxicity. 24 h after 
splenic cell delivery, mice were assessed for their cytotoxic re-
sponse to OVA-expressing splenocytes. Mice treated with WT 
apoptotic thymocytes displayed equal ratios of WT and OVA-
expressing splenocytes (Fig. 4 D). Mice treated with OVA apop-
totic thymocytes alone displayed slight cytotoxicity toward the 
OVA-expressing splenocytes. In contrast, there was almost com-
plete ablation of OVA-expressing splenocytes in mice treated 
with OVA apoptotic thymocytes and Poly I:C (Fig. 4 D). These 
data demonstrated that the addition of Poly I:C with apoptotic 
cells enhanced the cytotoxicity of antigen-specific T cells.
Overall,  pulmonary  CD103+  DCs  and  splenic  CD8+  
DCs share multiple attributes including growth factors and 
transcription factors that regulate them, chemokine and pattern 
recognition receptor expression, and functional proper-
ties such as preferential uptake of apoptotic cells and cross- 
presentation. However, there is one major functional difference 
between the nonlymphoid and lymphoid DCs: CD103+ DCs 
migrate down afferent lymphatics, whereas CD8+ DCs do 
not (Fig. S2 A; Smith and Fazekas de St Groth, 1999). There is 
a study that has shown that peptide-pulsed CD8+ and CD8 
splenic DCs elicit opposing immune responses (Maldonado-
López et al., 1999). Because we and others show that splenic 
CD8+ DCs do not migrate down afferent lymphatics, the   
immunological outcome observed by the delivery of peptide-
pulsed  splenic  CD8+  DCs  may  have  been  caused  by  the 
acquisition of dying CD8+ DCs by endogenous skin effero-
cytic  DCs  that  cross-present  in  the  draining  LN  (Bedoui   
et al., 2009). In contrast, CD8 DCs, either CX3CR1hi or 
CX3CR1lo (Fig. S2 B), do migrate to draining LNs to present 
the peptide-pulsed antigen, leading to the immunological out-
come observed (Smith and Fazekas de St Groth, 1999). The 
inability of splenic CD8+ DCs to migrate should caution the 
use of its human DC orthologue; for instance, if human blood 
CD141+ DCs were antigen pulsed and adoptively transferred 
into the dermis of patients, their lymphatic migratory capacity 
would need to be investigated. Alternatively, when designing JEM Vol. 208, No. 9  1795
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for 5 h in RPMI + 10% FCS containing 10 µM OVA257–264 and 10 µM 
OVA323–339 and 10 µg/ml Brefeldin A. After surface staining, cells were fixed 
in 4% paraformaldehyde and then blocked and permeabilized with PBS- 
saponin/milk. Cells were stained with APC conjugated to IFN- or isotype 
control (BD).
In vivo cytotoxic T cell assay. 1 d after OT-1 cell adoptive transfer, WT 
mice were administered by i.n. delivery with WT apoptotic or OVA apop-
totic cells ± 10 µg Poly I:C. 6 d after immunization, labeled WT and OVA 
splenocytes were injected i.v. WT spleen cells were labeled with 1 µM CFSE, 
and spleen cells from actin-OVA+ mice were labeled with 10 µM CFSE. La-
beled splenocytes were mixed in a 1:1 ratio before i.v. delivery of 107 cells/
mouse. The next day, spleens were harvested to acquire single-cell suspen-
sions, and specific killing of adoptively transferred CFSE+ low and high pop-
ulations was assessed by flow cytometry.
Microscopy. Pulmonary DC subsets were FACS sorted (MoFlo; Beckman 
Coulter) from whole lung digests 2 h after CFSE-labeled apoptotic thymo-
cytes were delivered i.n. Sorted DCs were stained with Image-iT LIVE 
plasma membrane and nuclear labeling kit (Invitrogen), and then cytospins 
were performed to deposit cells on positively charged glass slides. Images 
were obtained using an AxioVision microscope (Carl Zeiss), and efferocytic 
DCs were quantified using AxioVision digital imaging software (Carl Zeiss). 
DCs were considered efferocytic if CFSE+ vesicles were detected within the 
cellular membrane. To determine the percentage of CFSE+ DCs, 30–60 cells 
were counted in 25 randomized fields of view per sample.
Isolation of splenic and lung DCs for in vitro analysis. From single-
cell suspensions, isolation of CD45.2 splenic and lung DCs was performed 
using CD11c microbeads from Miltenyi Biotec. Miltenyi Biotec instruction 
for CD11c cell isolation was carefully followed. Triplicates of 1 × 105 DCs 
were cultured in 96-well flat-bottom plates in RPMI + 5% FCS, 50 µM 
mercaptoethanol, l-glutamine, streptomycin, and penicillin and allowed to 
rest for 1 h. After 1 h, Pacific blue succinimidyl ester (PBSE; Invitrogen)– 
labeled CD45.1 apoptotic thymocytes were cultured for 4 h at 37°C. After 
incubation, cells were harvested and stained for DC subsets from the lung and 
spleen. A final concentration of 1 mM EDTA was added to promote nonad-
herence of apoptotic cells on DCs. In addition, analysis to exclude externally 
adhered apoptotic cells on DCs was performed by excluding DCs expres-
sing CD45.1.
In vivo analysis of splenic DC migration CD45.2 splenic DC subsets 
were sorted using the BD Aria. Intradermal injections of splenic DCs were 
placed into the back skin of CD45.1 mice. 24 h after injection, skin-draining 
LNs were harvested, digested, and analyzed for DC migration. From single-
cell suspensions of CD45.2 CX3CR1gfp/gfg mice, isolation of the CD45.2 
splenic DCs was performed using CD11b microbeads from Miltenyi Bio-
tec, followed by sorting GFPhi and GFPlo DC–expressing subsets using the   
BD Aria.
Gene array. Whole-mouse genome Affymetrix gene arrays were performed 
with the Immunological Genome Project (ImmGen) at Harvard University 
(Heng and Painter, 2008). As per the specifications of ImmGen, we followed 
a standard operation procedure for the isolation and purification of all cell 
populations that is uniform across the ImmGen dataset. Procedures for cell 
isolation, sorting, and RNA extractions are outlined in extensive detail at 
http://www.immgen.org. Briefly, PBS-perfused lungs and spleens were di-
gested using 1.75 mg/ml Liberase Blendzyme 3 (Roche) for 15 min, filtered 
twice through a 100-µm nylon strainer, washed with HBSS, and then stained 
with conjugated flow cytometry antibodies (eBioscience) to identify pulmo-
nary DCs, pulmonary macrophages, splenic DCs, and splenic T cells. PI was 
used to exclude dead cells. Cell populations were sorted twice to enhance 
purity (BD Aria). The entire procedure from the time of sacrifice to cells   
collected in TRIZOL was completed in <3 h, which is a requirement by 
ImmGen. Flow plots of the actual sorts and cells used for RNA extraction 
All tissues were minced and then digested with 2.5 mg/ml collagenase D 
(Roche) for 30 min at 37°C. 100 µl of 100 mM EDTA was added to stop 
the digestion, and then the tissue was collected using a glass Pasteur pipette 
and pressed through a 100-µm nylon strainer for single-cell suspension. 
Spleens were treated with 7.5 ml of ammonium chloride lysing reagent 
(BD), followed rapidly by the addition of 7.5 ml HBSS. Cells were resus-
pended in FACS blocking solution and stained for 30 min with conjugated 
antibodies obtained from eBioscience and BD. The following purified mAbs 
were used for staining: Pacific blue–conjugated mAbs to CD8 and I-A/I-E; 
PE-conjugated mAbs to I-A/I-E, Siglec F, CD11b, CD8, or CD103; PerCP-
Cy5.5–conjugated mAbs to CD4 or CD11b; PE-Cy7–conjugated mAb to 
CD11c; and allophycocyanin-conjugated mAbs to CD103. CD36 was pur-
chased from BioLegend, and biotin-conjugated mAb to Clec9a was pro-
vided by M.H. Lahoud, I. Caminschi, and K. Shortman (Caminschi et al., 
2008). Appropriate isotype-matched control mAbs were also obtained from 
eBioscience, BD, and BioLegend. Flow cytometry was performed using the 
LSR II (BD), and data were analyzed with FlowJo (Tree Star).
Immunostaining. Frozen sections of the LLN and skin brachial-LN were 
fixed in 4% paraformaldehyde and stained with Cy5-B220 (eBioscience) or 
isotype-matched control antibody.
i.n. deliveries. Administration of i.n. deliveries was performed using an 
optimized delivery system previously described (Jakubzick et al., 2008a; 
Jakubzick and Randolph, 2010). In brief, mice were completely anesthe-
tized with Avertin using 300 µl per mouse with tert-amyl alcohol content at 
2.5% and 2,2,2 tribromoethanol (T1420; TCI America) at a concentration 
of 50 mg/kg. Cells or beads were diluted in PBS, and 50 µl of solution was 
delivered i.n. Final concentration of deliveries were 20 × 106 apoptotic cells ±2 µg   
LPS (Sigma-Aldrich), ±10 µg Poly I:C (InvivoGen), 1 µg sOVA (Sigma- 
Aldrich), and 30 × 106 of 0.5-, 1-, 2-, 3-, and 4.5-µm yellow-green carboxyl-
ated beads (Polysciences). In co-delivery experiments, 20 × 106 apoptotic 
cells and 30 × 106 2-µm beads were administered i.n. Mice were sacrificed   
at various times dependent on experimental design.
Apoptotic cell delivery. Thymocytes were obtained from C57BL/6 and 
BALB/c mice 7–8 wk of age. Single-cell suspensions were made using the 
rubber end of a syringe and mashing cells through a 40-µm nylon filter. 
Apoptosis of murine thymocytes and murine lung epithelial cells (MLE 12; 
American Type Culture Collection) was induced by 60 mJ UV radiation ex-
posure (StrataLinker 1800; Agilent Technologies) followed by 2-h (for thymo-
cytes) and 3-h (for epithelial cells) incubation at 37°C in RPMI + 10%   
FCS. Apoptosis of human neutrophils was induced by aging the cells over-
night at 5 × 106 cells/ml in RPMI + 10% FBS at 37°C in 5% CO2 in a   
25-cm2 TC flask (Frasch et al., 2011). Phosphatidylserine exposure was de-
tected by Annexin  V staining and propidium iodide (PI) to assure that no ne-
crotic cells were present before delivery. 2 h (for thymocytes) or 3 h (for 
epithelial cells) after UV exposure, cells were 60% apoptotic Annexin  V+ PI, 
40% were Annexin  V PI (but with time these cells would all become apop-
totic), and <0.2% were PI+. Apoptotic cells were labeled with 10 µM CFSE 
(Invitrogen) and then resuspended and washed three times in 30 ml RPMI + 
10% FCS before delivery.
Proliferation of OVA-specific transgenic CD8+ and CD4+ T cells. 
Spleen cells from OT-1 and OT-2 mice, in which the TCR of CD8+ and 
CD4+ cells are restricted to OVA were isolated and labeled with 10 µM 
CFSE. Half a million of these cells were transferred i.v. into recipient mice   
1 d before i.n. delivery of apoptotic cells and sOVA. Mice were sacrificed 3 d 
after i.n. deliveries for analysis of T cell proliferation (CFSE dye dilution) in 
the LLN and intracellular cytokine staining.
Intracellular cytokine staining. LLNs isolated 3 d after i.n. deliveries of 
apoptotic cells or sOVA ± Poly I:C were teased and digested in Collagenase D 
for 30 min and then pressed through a 100-µm nylon filter to obtain single-cell 
suspensions of APCs and proliferating T cells. Isolated cells were cultured   1796 Efferocytic pulmonary dendritic cells | Desch et al.
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may be viewed at http://www.immen.org. All datasets have been deposited 
in GEO DataSets under accession no. GSE15907. Validation for the use of 
pulmonary DC gene arrays was assessed by the confirmation of mRNA ex-
pression for known surface proteins, transcription factors, and growth factors 
associated with pulmonary DCs and controls to compare with splenic DCs, 
pulmonary macrophages, and splenic CD4 T cells (Table S2).
Statistics. Statistical analysis was conducted using InStat and Prism software 
(both from GraphPad Software). All results are expressed as the mean ± SEM. 
Statistical tests were performed using two-tailed Student’s t test. A value of   
P < 0.05 was considered statistically significant.
Online supplemental material. Fig. S1 displays the gating strategy for 
CFSE+ DCs in the LLN 24 h after i.n. delivery of CFSE-labeled apoptotic 
BALB/c  thymocytes,  human  neutrophils,  or  murine  lung  epithelial  cells 
(MLE 12). Fig. S2 demonstrates that splenic CD8+ DCs do not migrate 
down afferent lymphatics. Table S1, included as a separate PDF file, shows 
gene expression analysis for candidate phosphatidylserine receptors, bridging 
molecules, Toll-like receptors, and chemokine receptors for pulmonary DCs, 
pulmonary macrophages, and splenic CD4 T cells. Table S2, included as a 
separate PDF file, validates gene array for known protein expression associ-
ated with pulmonary DCs, splenic DCs, pulmonary macrophages, and splenic 
CD4 T cells. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20110538/DC1.
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